PP OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Dynaflex™ G2706 28A USP Class VI, ISO 10993, Food contact EtO Soft translucent grade, grippy feel Dynaflex™ G2711 43A USP Class VI, ISO 10993, Food contact EtO Highly colorable solution, grippy feel, low compression set Versaflex™ CL2242 & CL2250 42A/ 50A USP Class VI, ISO 10993, US Food contact EtO Clear boilable grades; ABS, PC bondable Versaflex™ G2705 N 60A USP Class VI, ISO 10993, Food contact EtO/Steam High resilience, low compression set Versaflex™ HC3810 20A-90A USP Class VI, ISO 10993 EtO General purpose, unfilled ABS, PC OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Versaflex™ OM1040 40A USP Class VI, ISO 10993 EtO Translucent Versaflex™ OM3060 60A USP Class VI, ISO 10993 EtO Clear VERSAFLEX™ CL AND DYNAFLEX™ TPEs OVERMOLDING FOR ERGONOMICS • Adds good tactile surface with soft-touch feel • Available in a variety of color effects and textures • Improves grip, cushion, and comfort • Enhances functional performance like sealing properties, vibration damping, oxygen barrier, and scratch and abrasion resistance • Reduces assembly costs, good processability • Offers excellent adhesion to a wide range of substrates Applications: • Glucometers • Medical tools overmolds • Injector pens • Analysis devices VERSALLOY™ HC & VERSAFLEX™ HC TPEs SEALING & RESEALING • Rubbery feel and soft touch • No coring, good puncture, and resealability in static stoppers • Meets low coefficient of friction requirements in dynamic seals • Low extractables • Suitable to overmold onto polyolefins Applications: • Sealing and resealing septum • Seals and sanitary gaskets • Syringe plungers and tips MATERIAL DESCRIPTION HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Versalloy™ HC 9210-45N 45A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9210-55N 55A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9210-70N 70A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9220-43N 43A USP Class VI, ISO 10993-4/5 EtO Extrusion grade, high temperature resistance Versaflex™ HC 2110-35N 34A FDA, USP Class VI, ISO 10993 Autoclave EtO radiation Resealing, elevated comp set Versaflex™ HC 2110-57B 57A FDA, USP Class VI, ISO 10993 Autoclave EtO radiation Low stiction VERSAFLEX™ CL AND DYNAFLEX™ TPEs HIGH CLARITY GRADES WITHOUT PLASTICIZERS • Water clear grades formulated without phthalate plasticizers • Meets medical regulatory USP Class VI and ISO 10993-4,5 • Food contact and FDA compliant • Autoclave and radiation stable • Low extractable • High clarity (Haze 50 4.1, 100 4.5, 100 4, 70 6, 70 Tensile Modulus (MPa) 2200 2700 2600 2350 1820 1820 Flexural Strength (MPa) 80 90 104 86 68 68 Flexural Modulus (MPa) 2500 2700 2500 2300 1980 1590 HDT: 0.45, 1.8 (MPa) 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70 UL-94 Rating @ 3.0 mm 5VA V-0 5VA V-0 HB V-0 UL-94 Rating @ 1.5 mm V-0 V-0 5VB V-0 HB V-0 UL-94 Rating @ 0.75 mm V-1 V-2 V-0 None None V-2 COMPETITIVE MATERIAL COMPARISON ENGINEERED POLYMER FORMULATIONS FOR HEALTHCARE TRILLIANT™ HC THERMOPLASTICS The family of Trilliant™ HC high-performance thermoplastics is formulated to meet the growing challenges of medical devices and equipment.

Orangeville Compound (Update 1) Report Preview National Pollutant Release Inventory (NPRI) and Partners Home Submission Management Help My Profile:Brian Greer Logout Ec.gc.ca Report Preview Report Details Company and Facility Details Permits Contacts Details Report Year 2016 Report Type: NPRI Report Status: Update 1 ­ Submitted Modified Date/Time: 13/03/2018 2:04 PM Report Update Comments: As per email from NPRI QC team Feb 13, 2018 Company Name: Polyone Canada Inc. lang=En&n=FD9B0E51-1 https://ec.ss.ec.gc.ca/auth/en/Services about:/ about:/ about:/ General Information Substance List CAS RN Substance Name Releases Releases (Speciated VOCs) Disposals Recycling Unit NA ­ 01 Antimony (and its compounds) 0.0004 N/A N/A N/A tonnes NA ­ 02 Arsenic (and its compounds) 0.0007 N/A N/A N/A kg 103­23­1 Bis(2­ethylhexyl) adipate 0.0106 N/A N/A N/A tonnes 117­81­7 Bis(2­ethylhexyl) phthalate 0.0283 N/A N/A N/A tonnes 85­68­7 Butyl benzyl phthalate 0.0008 N/A N/A N/A tonnes NA ­ 14 Zinc (and its compounds) 0.0000 N/A N/A 0.0002 tonnes Applicable Programs CAS RN Substance Name NPRI ON MOE TRA ON MOE Reg 127/01 First report for  this substance to  the ON MOE TRA NA ­ 01 Antimony (and its compounds) Yes NA ­ 02 Arsenic (and its compounds) Yes 103­23­1 Bis(2­ethylhexyl) adipate Yes 117­81­7 Bis(2­ethylhexyl) phthalate Yes 85­68­7 Butyl benzyl phthalate Yes NA ­ 14 Zinc (and its compounds) Yes Position: EHS Manager Telephone: 5192150535 Email: brian.greer@polyone.com Contact Type Certifying Official Name: Najat Kamal Position: EHSQ specialist Telephone: 5148089920 Email: najat.kamal@polyone.com Number of employees: 45 Activities for Which the 20,000­Hour Employee Threshold Does Not Apply: None of the above Activities Relevant to Reporting Dioxins, Furans and Hexacholorobenzene: None of the above Activities Relevant to Reporting of Polycyclic Aromatic Hydrocarbons (PAHs): Wood preservation using creosote: No Is this the first time the facility is reporting to the NPRI (under current or past ownership): No Is the facility controlled by another Canadian company or companies: No Did the facility report under other environmental regulations or permits: No Is the facility required to report one or more NPRI Part 4 substances (Criteria Air Contaminants): No Was the facility shut down for more than one week during the year: No Operating Schedule ­ Days of the Week: Mon, Tue, Wed, Thu, Fri Usual Number of Operating Hours per day: 24 Usual Daily Start Time (24h) (hh:mm): 00:00 General Information about the Substance ­ Releases and Transfers of the Substance CAS RN Substance Name Was the substance released on­site The substance will be reported as the sum of releases to all media (total of 1 tonne or less) 1 tonne or more of a Part 5 Substance (Speciated VOC) was released to air NA ­ 01 Antimony (and its compounds) Yes Yes No NA ­ 02 Arsenic (and its compounds) Yes No No 103­23­1 Bis(2­ethylhexyl) adipate Yes Yes No 117­81­7 Bis(2­ethylhexyl) phthalate Yes Yes No 85­68­7 Butyl benzyl phthalate Yes Yes No NA ­ 14 Zinc (and its compounds) Yes No No General Information about the Substance ­ Disposals and Off­site Transfers for Recycling CAS RN Substance Name Was the substance disposed of (on­site or off­ site), or transferred for treatment prior to final disposal Is the facility required to report on disposals of tailings and waste rock for the selected reporting period Was the substance transferred off­site for recycling NA ­ 01 Antimony (and its compounds) No No No NA ­ 02 Arsenic (and its compounds) No No No 103­23­1 Bis(2­ ethylhexyl) adipate No No No 117­81­7 Bis(2­ ethylhexyl) phthalate No No No 85­68­7 Butyl benzyl phthalate No No No NA ­ 14 Zinc (and its compounds) Yes No No General Information about the Substance ­ Nature of Activities CAS RN Substance Name Manufacture the Substance Process the Substance Otherwise Use of the Substance NA ­ 01 Antimony (and its compounds) For on­site use/processing As a reactant As a by­product NA ­ 02 Arsenic (and its compounds) For on­site use/processing As a reactant As a by­product 103­23­1 Bis(2­ethylhexyl) adipate For on­site use/processing As a reactant As a by­product 117­81­7 Bis(2­ethylhexyl) phthalate For on­site use/processing As a reactant As a by­product 85­68­7 Butyl benzyl phthalate For on­site use/processing As a reactant As a by­product NA ­ 14 Zinc (and its compounds) For on­site use/processing As a reactant As a by­product On­site Releases ­ Releases to air CAS RN Substance Name Category Basis of Estimate Detail Code Quantity NA ­ 02 Arsenic (and its compounds) Stack or Point Releases O ­ Engineering Estimates 0.0000 kg NA ­ 14 Zinc (and its compounds) Stack or Point Releases O ­ Engineering Estimates 0.0000 tonnes On­site Releases ­ Releases to air ­ Total CAS RN Substance Name Total ­ Releases to Air NA ­ 02 Arsenic (and its compounds) 0.0000 kg NA ­ 14 Zinc (and its compounds) 0.0000 tonnes On­site Releases ­ Releases to land CAS RN Substance Name Category Basis of Estimate Detail Code Quantity NA ­ 02 Arsenic (and its compounds) Other O ­ Engineering Estimates 0.0007 kg Onsite Releases ­ Nature of Other Land Release CAS RN Substance Name Nature of Other Land Release NA ­ 02 Arsenic (and its compounds) Landfill disposal CAS RN Substance Name Nature of Other Land Release On­site Releases ­ Releases to land ­ Total CAS RN Substance Name Total ­ Releases to Land NA ­ 02 Arsenic (and its compounds) 0.0007 kg Total Quantity Released (All Media) CAS RN Substance Name Category Basis of Estimate Detail Code Quantity NA ­ 01 Antimony (and its compounds) Total Quantity Released O ­ Engineering Estimates 0.0004 tonnes 103­23­1 Bis(2­ethylhexyl) adipate Total Quantity Released O ­ Engineering Estimates 0.0106 tonnes 117­81­7 Bis(2­ethylhexyl) phthalate Total Quantity Released O ­ Engineering Estimates 0.0283 tonnes 85­68­7 Butyl benzyl phthalate Total Quantity Released O ­ Engineering Estimates 0.0008 tonnes On­site Releases ­ Total CAS RN Substance Name Total releases NA ­ 02 Arsenic (and its compounds) 0.0007 kg NA ­ 14 Zinc (and its compounds) 0.0000 tonnes On­site Releases ­ Quarterly Breakdown of Annual Releases CAS RN Substance Name Quarter 1 Quarter 2 Quarter 3 Quarter 4 NA ­ 01 Antimony (and its compounds) 25 25 25 25 NA ­ 02 Arsenic (and its compounds) 25 25 25 25 103­23­1 Bis(2­ethylhexyl) adipate 25 25 25 25 117­81­7 Bis(2­ethylhexyl) phthalate 25 25 25 25 85­68­7 Butyl benzyl phthalate 25 25 25 25 On­site Releases ­ Reasons for Changes in Quantities Released from Previous Year CAS RN Substance Name Reasons for Changes in Quantities from Previous Year Comments 103­23­1 Bis(2­ethylhexyl) adipate No significant change (i.e. 

Sitting atop the plastics pyramid, high-temperature formulations provide robust material performance at elevated temperatures in excess of 300°F (150°C).  

Attachment 2 Tax adjustments(2) 2)

2 Omkoping van overheidsfunctionarissen 2 Commerciële omkoping 3 Faciliterende betalingen en smeergeld 3 Werken met vertegenwoordigers, distributeurs en andere derden 3 Due diligence- en goedkeuringsproces 3 Rode vlaggen 4 Vereisten op het gebied van boekhouding en administratie 4 Melden van mogelijke overtredingen 5 Ethische hotline van Avient 5 Bescherming tegen vergelding 5 Snelle verwijzing: ABAC WEL DOEN EN NIET DOEN 6 1 Ons internationale beleid tegen omkoping en corruptie Avient verbiedt ten strengste fraude, omkoping en andere corrupte bedrijfspraktijken bij al onze activiteiten overal ter wereld. Om te voldoen aan de ABAC-wetten, mag geen enkele medewerker of derde partij die namens Avient handelt, ooit enige vorm van geschenk, vermaak of iets van waarde aanbieden aan of ontvangen van iemand, direct of indirect, wanneer dat smeergeld bedoeld is om: • zakelijke overeenkomsten te verkrijgen of te behouden; 2 Dit omvat elke overheidsfunctionaris en/of werknemer uit de particuliere sector Inhoudsopgave 2 • zakelijke beslissingen te beïnvloeden; • een oneerlijk voordeel te verkrijgen.

2 Bestechung von Staatsbediensteten 2 Bestechung im Wirtschaftsleben 3 Gefälligkeitszahlungen und Schmiergelder 3 Zusammenarbeit mit Vertretern, Vertriebspartnern und anderen Drittparteien 3 Due Diligence und Genehmigungsverfahren 4 Warnsignale 4 Anforderungen an die Buchführung 4 Meldung möglicher Verstöße 5 Ethik-Hotline von Avient 5 Schutz vor Vergeltungsmaßnahmen 5 Kurzübersicht: Richtige und falsche Handlungsweisen im Zusammenhang mit ABAC 6 1 Unsere globale Richtlinie zur Bekämpfung von Bestechung und Korruption Avient untersagt ausdrücklich Betrug, Bestechung und andere korrupte Geschäftspraktiken bei all seinen Geschäftstätigkeiten weltweit. Darüber hinaus sind alle diese Personen dazu verpflichtet: • sich mit den anwendbaren Aspekten der Richtlinie vertraut zu machen und sie den ihnen unterstellten Mitarbeitern zu erläutern • Fragen zu stellen, wenn die Richtlinie oder die erforderliche Aktion, die in einer bestimmten Situation erfolgen muss, unklar ist • geschäftliche Aktivitäten, die über Drittparteien abgewickelt werden, vorgenommene zu managen und zu überwachen • aufmerksam auf potenzielles oder tatsächliches Fehlverhalten zu achten • Verstöße oder vermutete Verstöße über die angemessenen Kanäle umgehend zu melden ABAC-Gesetze untersagen es allen Unternehmen und Personen, einer Einzelperson2 geldwerte Zuwendungen anzubieten, zu versprechen, zu zahlen oder deren Zahlung zu genehmigen, um sich Geschäfte zu sichern oder zu 2 Dies gilt für alle Staatsbediensteten und/oder privatwirtschaftlich Beschäftigten Startseite | Inhaltsangabe 2 erhalten beziehungsweise um sich sonstige unzulässige Geschäftsvorteile zu verschaffen.

2 Soborno de funcionarios gubernamentales 2 Soborno comercial 3 Pagos de facilitación y comisiones 3 Trabajo con agentes, distribuidores y otros terceros 3 Proceso de diligencia debida y aprobación 3 Señales de alarma 4 Requisitos contables y de mantenimiento de registros 4 Informes de posibles infracciones 4 Línea Directa de Ética de Avient 5 Protección contra represalias 5 Referencia rápida: PUNTOS DEBE Y NO DEBE DE LA POLÍTICA ABAC 6 1 Nuestra Política Global contra el Soborno y la Corrupción Avient prohíbe estrictamente el fraude, el soborno y otras prácticas comerciales corruptas en todas nuestras operaciones comerciales en cualquier lugar del mundo. Esta prohibición es de aplicación tanto si la oferta o el pago se realiza directamente como a través de otra persona. 2 Esto incluye cualquier funcionario gubernamental o empleado del sector privado Índice 2 Para cumplir con las leyes ABAC, ningún empleado o tercero que actúe en nombre de Avient debería ofrecer nunca a nadie, ni recibir de nadie, directa o indirectamente, alguna forma de obsequio, entretenimiento o algo de valor cuando dicho soborno tenga como objetivo: • Obtener o retener un negocio • Incluir en decisiones comerciales • Asegurarse una ventaja injusta Las leyes ABAC son de amplio alcance y pueden interpretarse de manera muy amplia.

Special items for the fourth quarter of 2022 had a $(0.42) impact on EPS and included acquisition-related costs that primarily consist of inventory step-up adjustments, restructuring costs, debt extinguishment costs, and a pension market-to-market adjustment. 2 On a pro forma basis, fourth quarter and full year adjusted EPS were $0.42 and $3.04, respectively, which excludes special items and intangible amortization expense, exceeding previous guidance of $0.33 and $2.95. Three Months Ended December 31, 2022 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net (loss) income from continuing operations attributable to Avient shareholders $ (17.0) $ (0.19) $ 11.2 $ 0.12 Special items, after tax (Attachment 3) 38.3 0.42 23.9 0.26 Amortization expense, after-tax 14.6 0.16 11.3 0.12 Adjusted net income / EPS $ 35.9 $ 0.39 $ 46.4 $ 0.50 (1) Per share amounts may not recalculate from figures presented herein due to rounding Year Ended December 31, 2022 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 82.8 $ 0.90 $ 151.8 $ 1.65 Special items, after tax (Attachment 3) 116.2 1.26 50.0 0.54 Amortization expense, after-tax 49.0 0.53 44.9 0.49 Adjusted net income / EPS $ 248.0 $ 2.69 $ 246.7 $ 2.68 (1) Per share amounts may not recalculate from figures presented herein due to rounding 9 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Sales $ 790.4 $ 807.1 $ 3,396.9 $ 3,315.5 Cost of sales 618.4 590.5 2,514.2 2,371.7 Gross margin 172.0 216.6 882.7 943.8 Selling and administrative expense 171.6 166.4 639.4 664.1 Operating income 0.4 50.2 243.3 279.7 Interest expense, net (49.4) (17.5) (119.8) (75.2) Other expense, net (28.4) (5.3) (59.7) (1.0) (Loss) income from continuing operations before income taxes (77.4) 27.4 63.8 203.5 Income tax benefit (expense) 60.8 (17.1) 19.3 (51.9) Net (loss) income from continuing operations (16.6) 10.3 83.1 151.6 Income from discontinued operations, net of income taxes 561.5 18.7 620.3 79.0 Net income 544.9 29.0 703.4 230.6 Net (income) loss attributable to noncontrolling interests (0.4) 0.9 (0.3) 0.2 Net income attributable to Avient common shareholders $ 544.5 $ 29.9 $ 703.1 $ 230.8 Earnings per share attributable to Avient common shareholders - Basic: Continuing operations $ (0.19) $ 0.12 $ 0.91 $ 1.66 Discontinued operations 6.17 0.21 6.80 0.87 Total $ 5.98 $ 0.33 $ 7.71 $ 2.53 Earnings per share attributable to Avient common shareholders - Diluted: Continuing operations $ (0.19) $ 0.12 $ 0.90 $ 1.65 Discontinued operations 6.17 0.20 6.73 0.86 Total $ 5.98 $ 0.32 $ 7.63 $ 2.51 Cash dividends declared per share of common stock $ 0.2475 $ 0.2375 $ 0.9600 $ 0.8750 Weighted-average shares used to compute earnings per common share: Basic 91.0 91.5 91.2 91.4 Diluted 91.0 92.4 92.2 92.1 10 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Cost of sales: Restructuring costs, including accelerated depreciation $ (21.3) $ (6.0) $ (31.1) $ (14.6) Environmental remediation costs (0.4) (0.5) (24.2) (22.9) Reimbursement of previously incurred environmental costs — — 8.3 4.5 Acquisition related costs (23.8) 0.6 (34.1) (0.6) Impact on cost of sales (45.5) (5.9) (81.1) (33.6) Selling and administrative expense: Restructuring, legal and other (8.3) (4.2) (8.3) (5.9) Acquisition related costs (6.1) (1.1) (19.3) (8.3) Impact on selling and administrative expense (14.4) (5.3) (27.6) (14.2) Impact on operating income (59.9) (11.2) (108.7) (47.8) Interest expense, net - committed financing and debt extinguishment (16.0) — (26.0) — Mark-to-market on derivatives — — (30.9) — Pension and post retirement mark-to-market adjustment and other (28.4) (9.3) (28.4) (9.3) Impact on Other expense, net (28.4) (9.3) (59.3) (9.3) Impact on income from continuing operations before income taxes (104.3) (20.5) (194.0) (57.1) Income tax benefit benefit/(expense) on above special items 26.8 4.1 49.4 13.0 Tax adjustments(2) 39.2 (7.5) 28.4 (5.9) Impact of special items on net income from continuing operations $ (38.3) $ (23.9) $ (116.2) $ (50.0) Diluted earnings per common share impact $ (0.42) $ (0.26) $ (1.26) $ (0.54) Weighted average shares used to compute adjusted earnings per share: Diluted 91.7 92.4 92.2 92.1 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results 2) Tax adjustments include the net tax benefit/(expense) from non-recurring income tax items, adjustments to uncertain tax position reserves and deferred income tax valuation allowances. 11 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (Unaudited) (In millions) Year Ended December 31, 2022 2021 ASSETS Current assets: Cash and cash equivalents $ 641.1 $ 601.2 Accounts receivable, net 440.6 439.9 Inventories, net 372.7 305.8 Current assets held for sale — 360.2 Other current assets 115.3 119.9 Total current assets 1,569.7 1,827.0 Property, net 1,049.2 672.3 Goodwill 1,671.9 1,284.8 Intangible assets, net 1,597.6 925.2 Operating lease assets, net 60.4 58.2 Non-current assets held for sale — 22.0 Other non-current assets 136.2 207.7 Total assets $ 6,085.0 $ 4,997.2 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 2.2 $ 8.6 Accounts payable 454.4 429.5 Current operating lease obligations 17.0 21.1 Current liabilities held for sale — 141.3 Accrued expenses and other current liabilities 395.8 340.2 Total current liabilities 869.4 940.7 Non-current liabilities: Long-term debt 2,176.7 1,850.3 Pension and other post-retirement benefits 67.2 99.9 Deferred income taxes 342.5 100.6 Non-current operating lease obligations 40.9 37.3 Non-current liabilities held for sale — 13.1 Other non-current liabilities 235.5 164.8 Total non-current liabilities 2,862.8 2,266.0 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,334.5 1,774.7 Noncontrolling interest 18.3 15.8 Total equity 2,352.8 1,790.5 Total liabilities and equity $ 6,085.0 $ 4,997.2 12 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Year Ended December 31, 2022 2021 Operating activities Net income $ 703.4 $ 230.6 Adjustments to reconcile net income to net cash provided by operating activities: Gain on sale of business, net of tax expense (550.1) — Depreciation and amortization 157.6 144.2 Accelerated depreciation 5.5 1.7 Amortization of inventory step-up 34.4 1.5 Deferred income tax expense (benefit) 0.5 (27.3) Share-based compensation expense 13.2 11.2 Changes in assets and liabilities, net of the effect of acquisitions: Decrease (increase) in accounts receivable 32.6 (143.1) Decrease (increase) in inventories 14.0 (141.0) Increase in accounts payable 10.7 95.3 Increase (decrease) in pension and other post-retirement benefits 7.1 (10.9) Taxes paid on gain on divestiture (2.8) — (Decrease) increase in accrued expenses and other assets and liabilities, net (27.7) 71.6 Net cash provided by operating activities 398.4 233.8 Investing activities Capital expenditures (105.5) (100.6) Business acquisitions, net of cash acquired (1,426.1) (47.6) Settlement of foreign exchange derivatives 93.3 — Proceeds from divestiture 928.2 — Other investing activities 6.1 (2.0) Net cash used by investing activities (504.0) (150.2) Financing activities Debt offering proceeds 1,300.0 — Purchase of common shares for treasury (36.4) (4.2) Cash dividends paid (86.8) (77.7) Repayment of long-term debt (956.8) (18.5) Payments on withholding tax on share awards (4.3) (10.7) Debt financing costs (49.3) — Other financing activities — (3.5) Net cash provided (used) by financing activities 166.4 (114.6) Effect of exchange rate changes on cash (20.9) (17.3) Increase (decrease) in cash and cash equivalents 39.9 (48.3) Cash and cash equivalents at beginning of year 601.2 649.5 Cash and cash equivalents at end of year $ 641.1 $ 601.2 13 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Our recent performance demonstrates the resiliency of our portfolio during challenging times.” 2 As a continuation of its specialty transformation, the company announced in April it had entered into an agreement to acquire the DSM Protective Materials business (including the Dyneema® brand) (“Dyneema”) and that it is exploring the sale of its Distribution business. Three Months Ended June 30, 2022 Three Months Ended June 30, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income attributable to Avient shareholders $ 84.7 $ 0.92 $ 68.8 $ 0.74 Special items, after tax (Attachment 3) 5.1 0.06 11.7 0.13 Adjusted net income / EPS - excluding special items $ 89.8 $ 0.98 $ 80.5 $ 0.87 Six months ended June 30, 2022 Six months ended June 30, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income attributable to Avient shareholders $ 168.9 $ 1.83 $ 148.1 $ 1.60 Special items, after tax (Attachment 3) 12.3 0.13 14.3 0.16 Adjusted net income / EPS - excluding special items $ 181.2 $ 1.96 $ 162.4 $ 1.76 7 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Sales $ 1,302.4 $ 1,235.2 $ 2,596.2 $ 2,397.5 Cost of sales 998.6 946.5 1,998.7 1,806.4 Gross margin 303.8 288.7 597.5 591.1 Selling and administrative expense 174.3 180.6 339.4 362.6 Operating income 129.5 108.1 258.1 228.5 Interest expense, net (16.2) (19.5) (33.1) (38.8) Other income, net 1.4 1.2 0.8 2.7 Income before income taxes 114.7 89.8 225.8 192.4 Income tax expense (30.0) (20.4) (56.6) (43.3) Net income 84.7 69.4 169.2 149.1 Net income attributable to noncontrolling interests — (0.6) (0.3) (1.0) Net income attributable to Avient shareholders $ 84.7 $ 68.8 $ 168.9 $ 148.1 Earnings per share attributable to Avient common shareholders - Basic $ 0.93 $ 0.75 $ 1.85 $ 1.62 Earnings per share attributable to Avient common shareholders - Diluted $ 0.92 $ 0.74 $ 1.83 $ 1.60 Cash dividends declared per share of common stock $ 0.2375 $ 0.2125 $ 0.4750 $ 0.4250 Weighted-average shares used to compute earnings per common share: Basic 91.4 91.3 91.4 91.3 Diluted 92.1 92.4 92.2 92.3 8 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of sales: Restructuring costs, including accelerated depreciation and amortization $ (2.6) $ (1.5) $ (7.0) $ (3.3) Environmental remediation costs (3.0) (12.5) (5.0) (13.0) Reimbursement of previously incurred environmental costs 7.6 — 8.2 4.5 Acquisition related costs — 1.4 — 1.4 Impact on cost of sales 2.0 (12.6) (3.8) (10.4) Selling and administrative expense: Restructuring, legal and other (4.2) (0.4) (3.3) (1.7) Acquisition related costs (2.1) (1.2) (5.0) (4.5) Impact on selling and administrative expense (6.3) (1.6) (8.3) (6.2) Impact on operating income (4.3) (14.2) (12.1) (16.6) Other income, net — — 0.1 — Mark-to-market on cross-currency swaps 0.9 — 0.9 — Impact on income before income taxes (3.4) (14.2) (11.1) (16.6) Income tax benefit on above special items 0.8 3.4 2.8 4.3 Tax adjustments(2) (2.5) (0.9) (4.0) (2.0) Impact of special items on net income attributable to Avient Shareholders $ (5.1) $ (11.7) $ (12.3) $ (14.3) Diluted earnings per common share impact $ (0.06) $ (0.13) $ (0.13) $ (0.16) Weighted average shares used to compute adjusted earnings per share: Diluted 92.1 92.4 92.2 92.3 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results 2) Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. 9 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) June 30, 2022 December 31, 2021 ASSETS Current assets: Cash and cash equivalents $ 645.1 $ 601.2 Accounts receivable, net 752.6 642.3 Inventories, net 494.0 461.1 Other current assets 128.4 122.4 Total current assets 2,020.1 1,827.0 Property, net 638.9 676.1 Goodwill 1,256.8 1,286.4 Intangible assets, net 867.2 925.2 Operating lease assets, net 62.7 74.1 Other non-current assets 197.9 208.4 Total assets $ 5,043.6 $ 4,997.2 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 607.7 $ 8.6 Accounts payable 634.0 553.9 Current operating lease obligations 21.4 24.2 Accrued expenses and other current liabilities 307.5 353.9 Total current liabilities 1,570.6 940.6 Non-current liabilities: Long-term debt 1,249.1 1,850.3 Pension and other post-retirement benefits 95.0 100.0 Deferred income taxes 106.6 100.6 Non-current operating lease obligations 41.8 50.1 Other non-current liabilities 154.7 165.1 Total non-current liabilities 1,647.2 2,266.1 SHAREHOLDERS' EQUITY Avient shareholders’ equity 1,809.7 1,774.7 Noncontrolling interest 16.1 15.8 Total equity 1,825.8 1,790.5 Total liabilities and equity $ 5,043.6 $ 4,997.2 10 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Six Months Ended June 30, 2022 2021 Operating Activities Net income $ 169.2 $ 149.1 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 71.1 69.5 Accelerated depreciation and amortization 3.2 1.4 Share-based compensation expense 6.3 5.6 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (133.2) (196.1) Increase in inventories (45.9) (88.1) Increase in accounts payable 98.5 108.4 Decrease in pension and other post-retirement benefits (9.9) (9.2) (Decrease) increase in accrued expenses and other assets and liabilities, net (52.6) 27.5 Net cash provided by operating activities 106.7 68.1 Investing activities Capital expenditures (34.0) (42.1) Settlement of cross-currency swaps 75.1 — Net cash proceeds used by other assets — (2.0) Net cash provided (used) by investing activities 41.1 (44.1) Financing activities Purchase of common shares for treasury (36.4) (4.2) Cash dividends paid (43.5) (38.8) Repayment of long-term debt (4.4) (4.4) Payments of withholding tax on share awards (4.1) (4.2) Net cash used by financing activities (88.4) (51.6) Effect of exchange rate changes on cash (15.5) (5.7) Increase (decrease) in cash and cash equivalents 43.9 (33.3) Cash and cash equivalents at beginning of year 601.2 649.5 Cash and cash equivalents at end of period $ 645.1 $ 616.2 11 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

Both business segments performed well as we continue to capitalize on winning new business and gaining share, while serving the underlying market demand.” 2 Dr. Three Months Ended September 30, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 38.2 $ 0.41 $ 5.1 $ 0.06 Special items, after-tax (Attachment 3) 6.6 0.07 32.0 0.35 Amortization expense, after-tax 15.0 0.16 15.2 0.16 Adjusted net income / EPS $ 59.8 $ 0.65 $ 52.3 $ 0.57 (1) Per share amounts may not recalculate from figures presented herein due to rounding Nine Months Ended September 30, 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 121.2 $ 1.32 $ 48.0 $ 0.52 Special items, after-tax (Attachment 3) 33.9 0.37 73.9 0.81 Amortization expense, after-tax 44.7 0.49 46.5 0.51 Adjusted net income / EPS $ 199.8 $ 2.17 $ 168.4 $ 1.84 (1) Per share amounts may not recalculate from figures presented herein due to rounding 7 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Sales $ 815.2 $ 753.7 $ 2,493.9 $ 2,423.8 Cost of sales 553.8 558.4 1,696.7 1,740.2 Gross margin 261.4 195.3 797.2 683.6 Selling and administrative expense 184.2 161.0 553.5 529.9 Operating income 77.2 34.3 243.7 153.7 Interest expense, net (26.9) (30.3) (80.1) (88.5) Other (expense) income, net (0.3) 1.0 (2.1) 1.5 Income from continuing operations before income taxes 50.0 5.0 161.5 66.7 Income tax (expense) benefit (11.3) 0.1 (39.3) (18.0) Net income from continuing operations 38.7 5.1 122.2 48.7 Loss from discontinued operations, net of income taxes — — — (0.9) Net income $ 38.7 $ 5.1 $ 122.2 $ 47.8 Net income attributable to noncontrolling interests (0.5) — (1.0) (0.7) Net income attributable to Avient common shareholders $ 38.2 $ 5.1 $ 121.2 $ 47.1 Earnings (loss) per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.42 $ 0.06 $ 1.33 $ 0.53 Discontinued operations — — — (0.01) Total $ 0.42 $ 0.06 $ 1.33 $ 0.52 Earnings (loss) per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.41 $ 0.06 $ 1.32 $ 0.52 Discontinued operations — — — (0.01) Total $ 0.41 $ 0.06 $ 1.32 $ 0.51 Cash dividends declared per share of common stock $ 0.2575 $ 0.2475 $ 0.7725 $ 0.7425 Weighted-average shares used to compute earnings per common share: Basic 91.3 91.1 91.3 91.1 Diluted 92.3 91.9 92.0 91.8 8 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Cost of sales: Restructuring costs, including accelerated depreciation $ 1.8 $ (2.1) $ 5.6 $ (9.9) Environmental remediation costs (2.4) (38.1) (28.2) (52.5) Impact on cost of sales (0.6) (40.2) (22.6) (62.4) Selling and administrative expense: Restructuring and employee separation costs (3.1) (2.0) (6.6) (13.8) Legal and other (4.3) 1.7 (10.1) (9.1) Acquisition related costs (0.4) (0.5) (2.5) (4.6) Impact on selling and administrative expense (7.8) (0.8) (19.2) (27.5) Impact on operating income (8.4) (41.0) (41.8) (89.9) Interest expense, net - financing costs (1.3) (2.2) (2.3) (2.2) Other income (loss) — — 0.1 (0.1) Impact on income from continuing operations before income taxes (9.7) (43.2) (44.0) (92.2) Income tax benefit on special items 3.5 10.8 11.9 23.2 Tax adjustments(2) (0.4) 0.4 (1.8) (4.9) Impact of special items on net income from continuing operations $ (6.6) $ (32.0) $ (33.9) $ (73.9) Diluted earnings per common share impact $ (0.07) $ (0.35) $ (0.37) $ (0.81) Weighted average shares used to compute adjusted earnings per share: Diluted 92.3 91.9 92.0 91.8 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results 2) Tax adjustments include the net tax impact from non-recurring income tax items and certain adjustments to uncertain tax position reserves and valuation allowances. 9 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) September 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 505.7 $ 545.8 Accounts receivable, net 465.1 399.9 Inventories, net 377.8 347.0 Other current assets 108.8 114.9 Total current assets 1,457.4 1,407.6 Property, net 973.5 1,028.9 Goodwill 1,716.8 1,719.3 Intangible assets, net 1,542.5 1,590.8 Deferred income taxes 133.1 92.3 Other non-current assets 224.0 129.6 Total assets $ 6,047.3 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 7.8 $ 9.5 Accounts payable 425.9 432.3 Accrued expenses and other current liabilities 460.8 331.8 Total current liabilities 894.5 773.6 Non-current liabilities: Long-term debt 2,059.9 2,070.5 Pension and other post-retirement benefits 63.7 67.2 Deferred income taxes 289.1 281.6 Other non-current liabilities 359.9 437.6 Total non-current liabilities 2,772.6 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,363.0 2,319.2 Noncontrolling interest 17.2 18.8 Total equity 2,380.2 2,338.0 Total liabilities and equity $ 6,047.3 $ 5,968.5 10 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Nine Months Ended September 30, 2024 2023 Operating activities Net income $ 122.2 $ 47.8 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 133.1 142.6 Accelerated depreciation 1.2 1.9 Share-based compensation expense 12.5 9.7 Changes in assets and liabilities: Increase in accounts receivable (65.7) (5.7) (Increase) decrease in inventories (30.2) 16.5 Decrease in accounts payable (5.7) (59.1) Taxes paid on gain on sale of business — (104.1) Accrued expenses and other assets and liabilities, net (33.2) (2.5) Net cash provided by operating activities 134.2 47.1 Investing activities Capital expenditures (80.8) (75.0) Net proceeds from divestiture — 7.3 Proceeds from plant closures 3.4 — Other investing activities (2.1) 2.3 Net cash used by investing activities (79.5) (65.4) Financing activities Proceeds from long-term borrowings 650.0 — Payments on long-term borrowings (659.1) (103.8) Cash dividends paid (70.5) (67.6) Debt financing costs (9.6) (2.3) Other financing activities (4.6) (2.3) Net cash used by financing activities (93.8) (176.0) Effect of exchange rate changes on cash (1.0) (7.2) Decrease in cash and cash equivalents (40.1) (201.5) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of period $ 505.7 $ 439.6 11 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.